Exabis Library
Welcome to the e-CCO Library!
P540: Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P540: Longitudinal Dynamics of Gut Microbiome and Metabolome After Biological Therapy in Inflammatory Bowel Diseases
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P540: Real-world evidence on treatment switching in patients with moderate-to-severe ulcerative colitis: a systematic review of literature
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P540: The opinions and needs of patients living with refractory ulcerative proctitis, and the health care professionals who care for them; A Delphi consensus survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P540: Therapeutic drug monitoring in ustekinumab: which factors affect trough levels?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P541 Are we addressing the top ten research priorities in IBD?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P541: Clinical factors associated with discontinuation of combo or monotherapy for Crohn’s disease: A sub-analysis of a prospective randomised clinical trial (DIAMOND study)
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P541: Diagnosis, management, and evolution of acute pancreatitis secondary to thiopurines in patients with Inflammatory Bowel Disease: an ENEIDA registry study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P541: Effectiveness, safety and durability of vedolizumab in active moderate-severe Crohn's Disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P541: Efficacy, efficiency and aceptability of telemedicine for inflammatory bowel disease patients follow-up care during the COVID-19 pandemic lockdown.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P541: Intestinal failure: a rare but significant outcome of restorative proctocolectomy
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P541: Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: an IG-IBD study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P542 The effect of age on infliximab pharmacokinetics in patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P542: Clinical presentation, disease behavior and management of inflammatory bowel disease at extremes of age
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P542: Efficacy and safety of biological therapies in chronic antibiotic-refractory pouchitis: a retrospective single-centre experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P542: Infliximab salvage therapy in acute severe ulcerative colitis: A systematic review and meta-analysis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P542: Long-term outcomes after switching from originator infliximab to biosimilar in paediatric-onset inflammatory bowel disease patients: a single centre prospective observational study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P542: Short term efficacy, safety and thromboembolic risk of tofacitinib in moderate to severe Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P542: Topical tacrolimus versus systemic biological therapy for refractory ulcerative proctitis: a retrospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P543 UC remission mucosa displays upregulated inflammatory mediators
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM